NLRP3 and chronic myelogenous leukemia, BCR-ABL1 positive: Interestingly, NLRP3 and IL-1β mRNA expression levels were shown to be decreased, while IL-18 mRNA expression levels were shown to be increased in chronic myeloid leukemia (CML) compared to controls [217].